Vaxcyte PCVX
NASDAQ PCVX
$56.69 -1.58 (-2.71%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vaxcyte (PCVX) Interest Expenses (2019 - 2022)

Updated

Vaxcyte (PCVX) recorded Interest Expenses of $2,000 in FY2022, down 71.4% from $7,000 in FY2021.

Analysis

Vaxcyte (PCVX) Interest Expenses (2019 - 2022) Analysis & Trends

Starting with FY2018, Vaxcyte's Interest Expenses history includes 5 years.

  • Annual Interest Expenses has a four-year compound annual growth rate of -59.6% (FY2018 to FY2022).
  • The FY2022 figure is the lowest annual Interest Expenses in data going back to FY2018.
  • Per Business Quant data, PCVX's Interest Expenses was $7,000 in FY2021 (unchanged), $7,000 in FY2020 (-82.5%), $40,000 in FY2019 (-46.7%) and $75,000 in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 281.00 Mn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -435.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 247.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Vaxcyte 8.44 Bn 8.44 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 2,000.00
Jun 30, 2021 7,000.00
Mar 31, 2020 7,000.00
Dec 31, 2019 7,000.00
Sep 30, 2019 9,000.00
Jun 30, 2019 11,000.00
API Access

Vaxcyte Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=PCVX&period=max&api_key=YOUR_API_KEY